Page 27 - DRI ANNUAL REPORT EBOOK

Andy Morling
Head of Enforcement Medicines and Healthcare Products Regulatory Agency
Message
The Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s regulator for medicines and medical devices, values its collaboration with the government of India. Of particular importance is the strength of the relationship established between the Agency and India’s Directorate of Revenue Intelligence (DRI).
The criminal trade in medicines is substantially a cross-border one. It follows that meaningful, regular and timely international collaboration is essential both to protect the domestic interests of each nation and for each to play its part in defeating the global threat.
The MHRA’s Head of Enforcement, Andy Morling, has commented “The MHRA’s relationship with its partners in the DRI and in other Indian Government agencies is a strong example of what can be achieved when mutual trust and confidence is established. Those who seek to profit from crime across international borders can only be stopped by international understanding and collaboration of this kind. I am confident the resolve and shared endeavours of the DRI and the MHRA to work together in the prevention and detection of offending will be undiminished in 2021 and beyond.”
Even in this most challenging of years globally, the relationship between the MHRA and the DRI has prospered and continues to deliver outcomes for benefit of the people of both nations. The MHRA looks forward to continued collaboration with the DRI in the years ahead.
Andy Morling